Buy or sell: Stock recommendation by brokers for November 11, 2025

Analysts have downgraded Trent, citing weak consumption and competition, while Morgan Stanley maintains an overweight rating on Nykaa, impressed by its beauty and fashion business growth. Goldman Sachs holds a neutral stance on Divis Laboratories, noting strong Q2FY26 performance driven by custom synthesis.